⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28265333 | 1.00 | — | — | |
| SCHEMBL23123897 | 0.00 | — | — | |
| Hydrogen Sulfide SCHEMBL23805181 | 0.00 | — | — | |
| SCHEMBL23462036 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23462161 | 0.00 | CA4 (0.50) | — | |
| SCHEMBL23461972 | 0.00 | — | — | |
| SCHEMBL23462150 | 0.00 | — | — | |
| SCHEMBL23462232 | 0.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL25435623 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23462037 | 0.00 | CA4 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021183347-A1 | DYNAMIC HEALTH RECORDS | GINSBURG LEONARD H (US) | 2021-09-16 | — | — | WO | disclosed |
| EP-3516421-A2 | LIDAR SYSTEMS AND METHODS | Innoviz Technologies Ltd. (IL) | 2019-07-31 | — | — | EP | disclosed |
| EP-3148491-A1 | IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME | Glaukos Corporation (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-2996752-A1 | ORO-NASAL PATIENT INTERFACE | ResMed Limited (AU) | 2016-03-23 | — | — | EP | disclosed |
| WO-2015184173-A1 | IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES AND METHODS OF USING SAME | DOSE MEDICAL CORPORATION (US) | 2015-12-03 | — | — | WO | disclosed |
| EP-2931899-A1 | FUNCTIONAL GENOMICS USING CRISPR-CAS SYSTEMS, COMPOSITIONS, METHODS, KNOCK OUT LIBRARIES AND APPLICATIONS THEREOF | The Broad Institute, Inc. (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-2825654-A1 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | The Broad Institute, Inc. (US) | 2015-01-21 | — | — | EP | disclosed |
| WO-2014183167-A1 | ORO-NASAL PATIENT INTERFACE | RESMED LIMITED (AU) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014093595-A1 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | THE BROAD INSTITUTE, INC. (US) | 2014-06-19 | — | — | WO | disclosed |
| WO-2014093701-A1 | FUNCTIONAL GENOMICS USING CRISPR-CAS SYSTEMS, COMPOSITIONS, METHODS, KNOCK OUT LIBRARIES AND APPLICATIONS THEREOF | THE BROAD INSTITUTE, INC. (US) | 2014-06-19 | — | — | WO | disclosed |
| EP-2477478-A1 | A system for transformation of the chloroplast genome of Scenedesmus sp. and Dunaliella sp. | Sapphire Energy, Inc. (US) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011034863-A1 | A SYSTEM FOR TRANSFORMATION OF THE CHLOROPLAST GENOME OF SCENEDESMUS SP. AND DUNALIELLA SP. | SAPPHIRE ENERGY, INC. (US) | 2011-03-24 | — | — | WO | disclosed |
| EP-2215450-A2 | METHODS AND COMPOSITIONS FOR ANALYTE DETECTION | Nanogen Inc. (US) | 2010-08-11 | — | — | EP | disclosed |
| EP-1924596-A4 | ALBUMIN FUSION PROTEINS | HUMAN GENOME SCIENCES INC (US) | 2009-07-29 | — | — | EP | disclosed |
| EP-1998799-A2 | HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE | Medimmune, Inc. (US) | 2008-12-10 | — | — | EP | disclosed |
| EP-1924596-A2 | ALBUMIN FUSION PROTEINS | Human Genome Sciences, Inc. (US) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007103470-A2 | HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE | MEDIMMUNE, INC. (US) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007098184-A2 | METHODS AND COMPOSITIONS FOR ANALYTE DETECTION | NANOGEN, INC. (US) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007021494-A2 | ALBUMIN FUSION PROTEINS | HUMAN GENOME SCIENCES, INC. (US) | 2007-02-22 | — | — | WO | disclosed |